ALNY vs TXNM · P/E 76, rev $1.29B vs P/E 40, rev $2.17B
Alnylam Pharmaceuticals Inc (ALNY) versus TXNM Energy, Inc. (TXNM) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
TXNM Energy, Inc. (TXNM) is a utilities - regulated electric company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported TXNM revenue for 2025-12-31 was $2.17B. Net income was $169.8M. Revenue was up 9.9% from 2024-12-31 to 2025-12-31. TXNM currently screens at market cap $6.32B and trailing P/E 40.5.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. TXNM currently screens at market cap $6.32B and trailing P/E 40.5.
Not investment advice. Open the ALNY and TXNM stock pages for the full models.
Not investment advice.